| Strategies and challenges for the next generation of antibody–drug conjugates A Beck, L Goetsch, C Dumontet, N Corvaïa Nature reviews Drug discovery 16 (5), 315-337, 2017 | 1622 | 2017 |
| Strategies and challenges for the next generation of therapeutic antibodies A Beck, T Wurch, C Bailly, N Corvaia Nature reviews immunology 10 (5), 345-352, 2010 | 1011 | 2010 |
| Characterization of therapeutic antibodies and related products A Beck, E Wagner-Rousset, D Ayoub, A Van Dorsselaer, ... Analytical chemistry 85 (2), 715-736, 2013 | 609 | 2013 |
| Theory and practice of size exclusion chromatography for the analysis of protein aggregates S Fekete, A Beck, JL Veuthey, D Guillarme Journal of pharmaceutical and biomedical analysis 101, 161-173, 2014 | 312 | 2014 |
| Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins A Beck, E Wagner-Rousset, MC Bussat, M Lokteff, C Klinguer-Hamour, ... Current pharmaceutical biotechnology 9 (6), 482-501, 2008 | 294 | 2008 |
| Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry A Beck, S Sanglier-Cianférani, A Van Dorsselaer Analytical chemistry 84 (11), 4637-4646, 2012 | 282 | 2012 |
| A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor … L Goetsch, A Gonzalez, O Leger, A Beck, PJ Pauwels, JF Haeuw, ... International journal of cancer 113 (2), 316-328, 2005 | 275 | 2005 |
| Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody J Vlasak, MC Bussat, S Wang, E Wagner-Rousset, M Schaefer, ... Analytical biochemistry 392 (2), 145-154, 2009 | 254 | 2009 |
| Ion-exchange chromatography for the characterization of biopharmaceuticals S Fekete, A Beck, JL Veuthey, D Guillarme Journal of pharmaceutical and biomedical analysis 113, 43-55, 2015 | 233 | 2015 |
| Marketing approval of mogamulizumab: a triumph for glyco-engineering A Beck, JM Reichert MAbs 4 (4), 419-425, 2012 | 224 | 2012 |
| Antibody–drug conjugates: the last decade N Joubert, A Beck, C Dumontet, C Denevault-Sabourin Pharmaceuticals 13 (9), 245, 2020 | 202 | 2020 |
| Anti-IGF-IR antibodies and uses thereof L Goetsch, N Corvaia, O Leger, A Duflos, JF Haeuw, A Beck US Patent 7,241,444, 2007 | 197* | 2007 |
| The next generation of antibody-drug conjugates comes of age A Beck, JF Haeuw, T Wurch, L Goetsch, C Bailly, N Corvaïa Discovery medicine 10 (53), 329-339, 2010 | 190 | 2010 |
| Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry … D Ayoub, W Jabs, A Resemann, W Evers, C Evans, L Main, C Baessmann, ... MAbs 5 (5), 699-710, 2013 | 184 | 2013 |
| Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies A Beck, JM Reichert MAbs 3 (5), 415-416, 2011 | 184 | 2011 |
| Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry L Fornelli, D Ayoub, K Aizikov, A Beck, YO Tsybin Analytical chemistry 86 (6), 3005-3012, 2014 | 182 | 2014 |
| Innovative native MS methodologies for antibody drug conjugate characterization: high resolution native MS and IM-MS for average DAR and DAR distribution assessment F Debaene, A Boeuf, E Wagner-Rousset, O Colas, D Ayoub, N Corvaia, ... Analytical chemistry 86 (21), 10674-10683, 2014 | 181 | 2014 |
| Structure, heterogeneity and developability assessment of therapeutic antibodies Y Xu, D Wang, B Mason, T Rossomando, N Li, D Liu, JK Cheung, W Xu, ... MAbs 11 (2), 239-264, 2019 | 162 | 2019 |
| Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach S Fekete, A Beck, J Fekete, D Guillarme Journal of pharmaceutical and biomedical analysis 102, 33-44, 2015 | 150 | 2015 |
| Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults UF Power, TN Nguyen, E Rietveld, RL de Swart, J Groen, ... The Journal of infectious diseases 184 (11), 1456-1460, 2001 | 149 | 2001 |
Davy GUILLARMESenior lecturer, University of Geneva在 unige.ch 的电子邮件经过验证
